Rapid Response to High-Dose, Pulsatile Erlotinib in Afatinib-Refractory Leptomeningeal Carcinomatosis from Adenocarcinoma of the Lung: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|9|3|537-542

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.3, 2016-09, pp. : 537-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review

By  

Cardiology in the Young, Vol. 27, Iss. 5, 2016-12 ,pp. : 981-984

Cambridge University Press

Access to resources Recommend Favorite

Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-07 ,pp. : 666-670

Karger

Access to resources Recommend Favorite

Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 510-518

Karger

Access to resources Recommend Favorite

Response of Meningeal Carcinomatosis from Breast Cancer to Capecitabine Monotherapy: A Case Report

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-12 ,pp. : 840-846

Karger

Access to resources Recommend Favorite